TokenPost·
Moderna Shares Plunge 26% After Melanoma Vaccine Data Leak
-26%
Moderna share drop
The stock closed down 17.57%. The Phase 3 results showed lower risks of melanoma recurrence or death and distant metastasis or death.
More news
- TokenPostBitcoin ETF Flows Correlate More With Past Than Future Returns
- TokenPostGentherm Sets $3.5 Billion Revenue Opportunity for 2030 After Modine Deal
- Bitcoin.com NewsKraken Eyes Kazakhstan Market After Country Tightens Crypto Rules
- TokenPostSpotify Adds QR Checks and 12-Month Bar for Missed Family Verification
- TokenPostNVIDIA Launches Minerva Platform for AI Factory Observability
- TokenPostInfineum Explores Sale at Target Valuation Near $8 Billion